These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28317290)

  • 1. The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    Ti L; Dong H; Kerr T; Turje RB; Parashar S; Min JE; Montaner J; Wood E; Milloy MJ
    HIV Med; 2017 Sep; 18(8):580-586. PubMed ID: 28317290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting.
    Loh J; Kennedy MC; Wood E; Kerr T; Marshall B; Parashar S; Montaner J; Milloy MJ
    AIDS Care; 2016 Nov; 28(11):1448-54. PubMed ID: 27248328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.
    Lake S; Kerr T; Capler R; Shoveller J; Montaner J; Milloy MJ
    Int J Drug Policy; 2017 Apr; 42():63-70. PubMed ID: 28336000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.
    Richardson LA; Kerr TH; Dobrer S; Puskas CM; Guillemi SA; Montaner JS; Wood E; Milloy MJ
    AIDS; 2015 Nov; 29(18):2487-95. PubMed ID: 26558546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.
    Kennedy MC; Kerr TH; Wood E; Shoveller JA; Montaner JSG; Milloy MS
    AIDS; 2018 May; 32(8):1059-1067. PubMed ID: 29424782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
    Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
    J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
    AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs.
    Kennedy MC; Kerr T; McNeil R; Parashar S; Montaner J; Wood E; Milloy MJ
    AIDS Behav; 2017 Mar; 21(3):678-687. PubMed ID: 26906022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative.
    Milloy MJ; Wood E; Kerr T; Hogg B; Guillemi S; Harrigan PR; Montaner J
    Clin Infect Dis; 2016 Mar; 62(5):640-7. PubMed ID: 26553011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs.
    Stover S; Milloy MJ; Grant C; Fairbairn N; Socías ME
    AIDS; 2022 Jul; 36(9):1233-1243. PubMed ID: 35833680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of supervised drug consumption services on access to and engagement with care at a palliative and supportive care facility for people living with HIV/AIDS: a qualitative study.
    McNeil R; Dilley LB; Guirguis-Younger M; Hwang SW; Small W
    J Int AIDS Soc; 2014; 17(1):18855. PubMed ID: 24629844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
    Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
    AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
    Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
    BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.
    Ickowicz S; Wood E; Dong H; Nguyen P; Small W; Kerr T; Montaner JSG; Milloy MJ
    Drug Alcohol Depend; 2017 Nov; 180():33-38. PubMed ID: 28865390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis.
    Milloy MJ; Kerr T; Salters K; Samji H; Guillemi S; Montaner J; Wood E
    BMC Infect Dis; 2013 Dec; 13():565. PubMed ID: 24289651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated approach to care attracts people living with HIV who use illicit drugs in an urban centre with a concentrated HIV epidemic.
    Fernando S; McNeil R; Closson K; Samji H; Kirkland S; Strike C; Turje RB; Zhang W; Hogg RS; Parashar S
    Harm Reduct J; 2016 Nov; 13(1):31. PubMed ID: 27876048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.
    Ickowicz S; Salleh NAM; Fairbairn N; Richardson L; Small W; Milloy MJ
    AIDS Behav; 2019 Sep; 23(9):2634-2639. PubMed ID: 31236749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of residual viraemia during combination HIV treatment: Impacts of baseline HIV RNA levels and treatment choice.
    McKinnon E; Castley A; Payne L; Pummer S; Nolan D
    HIV Med; 2016 Aug; 17(7):495-504. PubMed ID: 26537660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.